Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Noriega

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Vaccine|August 1, 1994
Kinetics of the vibriocidal antibody response to live oral cholera vaccinesS S Wasserman, G A Losonsky, F Noriega, et al.
Archivos De La Sociedad Espanola De Oftalmologia|January 2, 2020
Knowledge of open angle glaucoma questionnaire: Design and validation in Spanish-speaking patients of PeruF Munayco-Guillén, J F Noriega-Cerdán, R R Cámara-Reyes, et al.
Journal of Biotechnology|January 26, 1996
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectorsM M Levine, J Galen, E Barry, et al.
Revista De Gastroenterologia De Mexico|August 13, 2009
[Comparative study of the clinical presentation and complications of acute colonic diverticulitis in patients older and younger than 65 years.]J Lizardi-Cervera, G Vázquez-Elizondo, I Becerra-Laparra, et al.
Revista Espanola De Cardiologia|October 22, 1998
[Acute myocarditis caused by varicella virus]F Noriega Peiró, M I Costas Alonso, M Vilar Freire, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|August 26, 1998
[Polymyalgia syndrome and atrial myxoma]N Gómez Rodríguez, M Vilar Freire, J L Ferreiro Seoane, et al.
Human Vaccines|October 3, 2006
Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of ageD W Scheifele, S A Halperin, E Rubin, et al.
The Science of the Total Environment|February 12, 2022
Brassica sprouts exposed to microplastics: Effects on phytochemical constituentsM D López, M T Toro, G Riveros, et al.
Infection and Immunity|November 1, 1996
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virGK L Kotloff, F Noriega, G A Losonsky, et al.
European Journal of Haematology|April 29, 2014
Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutationCristian A Ferri, Michele Bianchini, Raquel M Bengió, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Vaccine|August 1, 1994
Kinetics of the vibriocidal antibody response to live oral cholera vaccinesS S Wasserman, G A Losonsky, F Noriega, et al.
Archivos De La Sociedad Espanola De Oftalmologia|January 2, 2020
Knowledge of open angle glaucoma questionnaire: Design and validation in Spanish-speaking patients of PeruF Munayco-Guillén, J F Noriega-Cerdán, R R Cámara-Reyes, et al.
Journal of Biotechnology|January 26, 1996
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectorsM M Levine, J Galen, E Barry, et al.
Revista De Gastroenterologia De Mexico|August 13, 2009
[Comparative study of the clinical presentation and complications of acute colonic diverticulitis in patients older and younger than 65 years.]J Lizardi-Cervera, G Vázquez-Elizondo, I Becerra-Laparra, et al.
Revista Espanola De Cardiologia|October 22, 1998
[Acute myocarditis caused by varicella virus]F Noriega Peiró, M I Costas Alonso, M Vilar Freire, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|August 26, 1998
[Polymyalgia syndrome and atrial myxoma]N Gómez Rodríguez, M Vilar Freire, J L Ferreiro Seoane, et al.
Human Vaccines|October 3, 2006
Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of ageD W Scheifele, S A Halperin, E Rubin, et al.
The Science of the Total Environment|February 12, 2022
Brassica sprouts exposed to microplastics: Effects on phytochemical constituentsM D López, M T Toro, G Riveros, et al.
Infection and Immunity|November 1, 1996
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virGK L Kotloff, F Noriega, G A Losonsky, et al.
European Journal of Haematology|April 29, 2014
Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutationCristian A Ferri, Michele Bianchini, Raquel M Bengió, et al.
Pageof 3